Why Supply Chain Mapping Has Become a 2026 Insurance Underwriting Question for Indian Manufacturers
The decade from 2015 to 2025 demonstrated that Indian manufacturing supply chains are deeply integrated into global production networks and equally deeply exposed to disruption events outside the manufacturer's direct control. The covid-19 pandemic, the 2021 semiconductor shortage, the 2022 Ukraine conflict effects on energy and grain markets, the 2023 Red Sea shipping disruption, the 2024 Taiwan earthquake, and the 2024-25 rare-earth export restrictions from China have together produced a continuous education for Indian manufacturers on supply chain vulnerability. By 2026, the question facing Indian manufacturing risk managers is no longer whether disruption events will occur but how to map exposure to such events and how to finance the residual risk that operational measures cannot eliminate.
The Production Linked Incentive (PLI) schemes operative since FY2020-21 across electronics, semiconductors, pharmaceuticals, textiles, automotive and other sectors have substantially expanded Indian manufacturing scale. The Semicon India Programme with INR 76,000 crore in announced incentive support has anchored Indian semiconductor fabrication ambitions, with Tata Electronics, Micron, CG Power, Kaynes Semicon and others advancing project plans through 2024-26. The pharmaceutical sector, supplying approximately 60% of global vaccine demand and material shares of US generic and bulk drug demand, continues to depend on imported APIs (active pharmaceutical ingredients) and KSMs (key starting materials) sourced predominantly from China. The automotive sector's transition to electric vehicles has created new dependencies on lithium-ion battery components, electric motor magnets requiring rare-earth elements, and power electronics requiring specialised semiconductor capacity.
The supply chain mapping question in 2026 spans three increasingly granular tiers. Tier-1 suppliers are direct vendors with whom the manufacturer has commercial contracts; visibility is generally good and operational management is straightforward. Tier-2 suppliers supply the Tier-1 vendors; visibility requires explicit effort because contractual relationships do not flow through. Tier-3 suppliers supply the Tier-2 vendors; visibility at this depth is rare in Indian manufacturer practice and is the underwriting blind spot that drives uninsured loss when deep-tier disruption occurs.
For insurance underwriting, the Tier-2/Tier-3 visibility question affects three cover heads directly. Contingent business interruption (CBI) cover responds to revenue loss at the insured manufacturer arising from physical damage at a supplier's location; the cover requires identification of dependent suppliers and physical perils that affect their operations. Trade disruption insurance, an emerging product in the Indian market, responds to revenue loss from non-physical disruption events including export restrictions, sanctions, and logistics disruption. Stock throughput insurance responds to property and transit exposure across the supply chain from origin to destination, including warehoused inventory at intermediate points. Each cover requires supplier-level information that the manufacturer must develop and maintain.
The Indian insurance market's CBI cover scope has expanded through 2022-26 from a relatively narrow product to a more sophisticated offering. ICICI Lombard, HDFC Ergo, Bajaj Allianz, TATA AIG, Reliance General and New India Assurance all now offer CBI cover with varying degrees of supplier specificity. Foreign reinsurer engagement through GIC Re and direct foreign reinsurer programmes has expanded the available limits. The 2026 underwriting environment can support CBI placements at INR 50 to 500 crore for mid-to-large Indian manufacturers with documented supply chain mapping; placements beyond INR 500 crore require structured engagement with foreign reinsurer panels and may require parametric or trade disruption product overlays.
This post examines the supply chain mapping discipline that 2026 underwriting requires, the specific cover heads available and their scope conditions, the sector-specific risk patterns across semiconductor, pharma and broader manufacturing, the visibility tools and platforms supporting the mapping discipline, and the practical playbook for Indian manufacturer risk managers building integrated supply chain risk financing programmes.
The Supply Chain Mapping Discipline: Tier-1 Through Tier-3 Visibility
Effective supply chain mapping is a structured discipline that integrates procurement, operations, finance and risk management functions around a common dataset of supplier relationships and dependency intensities. The 2026 Indian manufacturer practice has matured materially from the patchwork approach common in 2018-21, with leading manufacturers building dedicated supply chain risk teams reporting to Chief Risk Officer or Chief Procurement Officer functions.
The Tier-1 mapping foundation begins with the manufacturer's procurement system data. Modern ERP platforms (SAP, Oracle, Microsoft Dynamics, locally-developed solutions) maintain vendor master records including legal entity name, registered address, supply categories, contract terms, payment history, and recent transaction volumes. The Tier-1 mapping enriches this baseline with operational risk data including primary manufacturing location for the supplied items (often different from the supplier's registered office), alternative manufacturing locations the supplier maintains, supplier financial health indicators, and supplier insurance status. The enrichment typically requires direct supplier engagement through structured questionnaires, supplier visits, and shared compliance assessments.
The Tier-2 mapping requires extending visibility into the supplier's own supplier base. This step is materially harder than Tier-1 because contractual leverage is limited and supplier willingness to disclose deeper-tier relationships varies. The 2026 best practice combines three approaches. First, contractual disclosure requirements in the Tier-1 supplier agreement obligate the supplier to disclose key Tier-2 dependencies, particularly for critical components and substances. Second, joint supplier development programmes for strategic items produce shared visibility into the underlying production base. Third, third-party intelligence services including D&B, Resilinc, Interos, Everstream Analytics, DHL Resilience360, and emerging Indian providers can map deeper-tier relationships using commercial trade data, import-export records, and proprietary supply chain intelligence.
The Tier-3 mapping is the visibility frontier where most Indian manufacturers have only fragmentary information. The complexity at Tier-3 reflects the underlying global production network: a semiconductor going into an electronics product manufactured in India may originate at a fab in Taiwan, with the silicon wafer originating in Japan, the photoresist chemicals in Germany, and the substrate materials in Korea. Each of these Tier-3 origins represents a potential disruption point with limited visibility to the Indian electronics manufacturer.
The 2024-25 emergence of dedicated supply chain visibility platforms in India has begun to address the visibility gap at scale. Locus has built logistics intelligence including supplier proximity, route exposure, and inventory positioning; while primarily transportation-focused, the platform provides supplier visibility components. Delhivery as a logistics operator and increasingly as a logistics intelligence provider has visibility into shipment patterns that surface supplier dependency information. Shiprocket in the ecommerce logistics layer provides downstream visibility that complements upstream supplier mapping. GoComet, FreightFox and TransportSimple in the freight and logistics intelligence layer provide further visibility components. None of these platforms individually solves the supply chain mapping problem, but integration of multiple data sources with manufacturer ERP data produces a credible Tier-1 and partial Tier-2 visibility picture.
For sectors with specific high-risk dependencies, dedicated mapping tools exist. The semiconductor supply chain is mapped by specialised intelligence providers including TechInsights, TrendForce, and SemiAnalysis providing fab-level production capacity data, wafer flow analytics, and technology node mapping. The pharmaceutical API supply chain is tracked by Tridge, PharmaCompass and CPhI Online providing API source mapping, manufacturer capacity intelligence, and price tracking. The rare-earth and critical minerals supply chain is tracked by Adamas Intelligence, Benchmark Mineral Intelligence, and increasingly by Indian sector-specific intelligence as the Critical Minerals Mission and National Critical Minerals Strategy under the Ministry of Mines develop institutional mapping capability.
The mapping output that supports insurance underwriting is a structured document typically including, for each critical material or component category: the primary Tier-1 supplier, alternative Tier-1 suppliers and their qualified status, the dominant Tier-2 production locations and their concentration risk, identified Tier-3 dependencies where critical, the historical disruption events affecting the category, the operational mitigations in place (inventory buffer, alternative qualified sources, in-house substitution capability), and the residual unmitigated exposure. The document supports the CBI policy supplier endorsement schedule, the trade disruption policy named-cause schedule, and the parametric programme trigger calibration.
The maintenance cycle for supply chain mapping is at least annual and ideally semi-annual or quarterly for critical categories. Supplier financial position, qualified status, production capacity and operational risk profile change continuously, and stale maps produce both operational decisions on outdated information and insurance disclosure issues if material changes are not communicated to insurers. Manufacturers should integrate supply chain mapping updates with the renewal cycle for affected covers, ensuring that the insurer endorsement schedule reflects current reality at each renewal.
Contingent Business Interruption Cover: Scope, Limits and Indian Market Practice
Contingent business interruption (CBI) insurance is the primary financial instrument for supply chain disruption risk in commercial insurance markets globally and in India. The cover responds when physical damage at a supplier's premises causes operational impact at the insured manufacturer, with indemnity for the manufacturer's revenue loss subject to cover scope, limits and deductibles.
The Indian CBI cover scope in 2026 typically includes three sub-categories of supplier dependency. Named supplier cover identifies specific suppliers in the policy schedule, with cover responding only to disruption at those identified entities; this is the most common structure for Indian placements and provides clear underwriter and broker visibility. Unnamed supplier cover, less common, provides limited cover for disruption at any supplier meeting defined criteria (often a specified percentage of input value or a specified category); this structure provides broader coverage but at higher premium and with stricter exclusions. Tier-2 supplier cover extends to suppliers of the named Tier-1 suppliers, with limits and conditions typically more restrictive than direct supplier cover.
The scope of perils triggering CBI cover follows the underlying business interruption policy. Fire and special perils CBI responds to fire, lightning, explosion, riot, strike, malicious damage and named natural perils at supplier locations. All-risks CBI responds to broader physical damage causes subject to standard exclusions. The cover does not respond to non-physical disruption causes including export restrictions, sanctions, supplier insolvency without physical damage, cyber events at supplier locations (unless specifically extended), or logistics disruption without physical damage at supplier or transit premises.
The limits and indemnity period structure typically aligns the CBI cover with the manufacturer's own BI cover. A manufacturer with INR 200 crore BI limit and 18-month indemnity period might place CBI cover at INR 100 to 150 crore with 12 to 18-month indemnity period, reflecting the underwriting view that supplier disruption typically produces less severe and somewhat shorter outage than direct facility damage. The CBI deductible structure typically includes both time-element (24 to 72 hours typical) and monetary (INR 25 lakh to INR 5 crore depending on programme scale) components.
Indian CBI cover pricing in 2026 has moderated from the post-covid hardening of 2021-23 but remains materially higher than pre-pandemic levels. Typical pricing for a mid-sized manufacturer with documented supply chain mapping and reasonable concentration profile sits at 0.10% to 0.40% of the CBI limit per year, with adjustments for sector (semiconductor and pharma APIs attract higher rates), supplier concentration (single-supplier dependency attracts higher rates), and historical experience (manufacturers with prior CBI claims pay materially more). The pricing differential between Indian onshore and foreign reinsurer markets has narrowed substantially, with GIFT City IFSC insurer engagement and Lloyd's market access through registered brokers providing competitive alternatives for larger placements.
The coverage exclusions and conditions deserve specific attention because they define where the cover does not respond. Common exclusions include disruption from causes outside the named perils (the trade disruption gap discussed in the next section), disruption from suppliers not specifically scheduled (where named supplier structure applies), disruption during periods where supplier insurance had lapsed or was inadequate (the supplier insurance condition), war and political risk events (unless specifically extended), nuclear and radiological events, and asbestos-related events.
The supplier insurance condition is a particularly important and often overlooked coverage condition. Most CBI cover requires that the named supplier maintain its own property and BI insurance to specified minimums; cover responds at the manufacturer level only when the supplier's own insurance has responded to the underlying physical damage. This condition produces three operational implications. First, the manufacturer must verify supplier insurance status as part of supplier onboarding and renewal cycles. Second, supplier insurance lapses can produce CBI coverage gaps even where physical damage clearly occurred. Third, supplier insurance disputes (where supplier insurance is contested or where supplier coverage is inadequate) can delay CBI claims response.
For named supplier cover, the schedule maintenance is a continuous operational task. Adding new strategic suppliers, removing exited suppliers, and updating concentration ratings produce policy endorsement activity through the policy year. Brokers placing CBI cover for active manufacturers should establish endorsement procedures with insurers that enable mid-term schedule changes without renewal-level negotiation, supporting the dynamic supply base management that manufacturers must operate.
The claims process for CBI events presents specific complexity beyond standard BI claims. The proximate cause analysis must establish physical damage at the supplier location (typically with surveyor verification at the supplier premises), causation linking the supplier disruption to the manufacturer's operational impact (often requiring detailed production and procurement records), and quantum analysis of the manufacturer's revenue loss accounting for mitigations including alternative sourcing, expedited shipping, and inventory utilisation. Surveyors and forensic accountants engaged on CBI claims require both Indian operations knowledge and supplier location access (which may be international); engagement protocols should be established pre-loss with named providers.
Trade Disruption Insurance and Non-Physical Disruption Cover
The CBI cover gap for non-physical disruption causes has become increasingly significant in the 2020-26 environment as manufacturers have experienced repeated disruption from sanctions, export restrictions, regulatory changes, cyber events, and logistics disruption without underlying physical damage. Trade disruption insurance (TDI) has emerged as a structured product addressing this gap, with the Indian market beginning to engage with the product through 2024-26.
Trade disruption insurance responds to revenue loss at the insured manufacturer arising from defined non-physical disruption events affecting the supply chain. The product is offered globally by specialty insurers including Liberty Specialty Markets, Beazley, Allianz Global Corporate & Specialty (AGCS), Munich Re, and selected Lloyd's syndicates. Indian market access is typically through foreign reinsurer programmes structured by specialty brokers, with cover written by foreign insurers and accessed by Indian manufacturers through specific structuring including GIFT City IFSC routing for larger placements.
The perils typically covered include export restrictions and sanctions imposed by foreign governments on supplier countries, regulatory changes producing supplier shutdown, port closures and logistics disruption from causes other than physical damage, supplier financial failure where contractual continuity is broken, and (with specific extension) certain cyber events at supplier locations. The cover does not respond to physical damage perils already covered under CBI, the manufacturer's own operational decisions, foreseeable events, gradual market changes, and standard exclusion heads including war, nuclear and political violence at the insured location.
The limits and pricing structure for trade disruption cover is materially different from CBI. Limits typically range from INR 25 to 250 crore on Indian placements, with higher limits available through structured layered programmes. The indemnity period typically extends to 12 to 36 months from disruption onset. Pricing varies significantly by perils included, supplier concentration, sector exposure, and historical experience, with typical rates running 0.25% to 1.5% of the cover limit per year, materially higher than CBI rates.
The semiconductor sector has been a particularly active user of trade disruption cover in 2024-26 given the multiple disruption events affecting global semiconductor supply. The Taiwan concentration risk for advanced node semiconductors, the China export control framework affecting certain chip categories, and the periodic disruption of intermediate substrate and chemical supply have together created sustained demand for cover beyond the physical perils captured under CBI. Indian electronics manufacturers including Dixon Technologies, Foxconn India, Wistron India (now part of Tata Electronics), and emerging semiconductor sector entrants have engaged with trade disruption cover for specific exposure categories.
The pharmaceutical sector exposure to API supply disruption from China has produced parallel engagement with trade disruption cover. Sun Pharma, Dr Reddy's, Lupin, Cipla, Aurobindo Pharma and Glenmark all face concentrated China dependency for specific APIs and KSMs, with disruption events through 2020-25 demonstrating the operational impact of supply restrictions. Trade disruption cover for the API dependency, structured to respond to specific export restriction triggers and supplier shutdown causes, provides risk financing for the gap that CBI cannot fill.
Parametric insurance structures provide a third risk financing tool for specific supply chain disruption risks. Parametric covers pay defined amounts on the occurrence of objectively measurable trigger events, without the loss adjustment process of indemnity insurance. For supply chain risks, parametric triggers can include named port closure days, named country export restriction notification, freight index volatility, and currency volatility affecting supplier payment terms. The parametric product range in the Indian market is developing through 2024-26 with Swiss Re and Munich Re leading product structuring, but specific parametric products for supply chain risks remain at limited scale.
The combination of CBI cover for physical perils, trade disruption cover for non-physical disruption, and parametric overlays for specific named risks provides a layered risk financing structure that addresses the full disruption risk profile. Indian manufacturers building integrated risk financing programmes increasingly adopt this layered approach for material supply chain exposures, with broker support for product structuring and reinsurer engagement that the layered approach requires.
The CBI / BI interaction at the policy level is a complex coverage question that brokers must address explicitly. Where both CBI cover and direct BI cover respond to the same disruption event (a supplier event also affecting the manufacturer's own operations through chained impact), the policies typically include specific anti-stacking provisions to avoid double recovery. The exact wording varies by carrier; brokers should review the interaction language at policy placement and document the expected response in the broker engagement file.
Sector-Specific Supply Chain Risk Patterns: Semiconductor, Pharmaceutical, Automotive and Textiles
The supply chain risk profile varies materially across Indian manufacturing sectors, with each sector exposing specific concentration patterns, regulatory dynamics and disruption triggers that should inform the supply chain mapping discipline and the insurance cover design. The four sectors examined below represent the bulk of Indian manufacturing supply chain insurance demand in 2026.
Semiconductor and Electronics Manufacturing
The Indian semiconductor and electronics manufacturing sector has expanded rapidly through 2020-26 under PLI scheme support, with Tata Electronics, Foxconn India, Wistron operations (now Tata-controlled), Pegatron India, Dixon Technologies and emerging fab projects representing the leading manufacturing base. The supply chain exposure is dominated by upstream semiconductor and component dependencies that originate predominantly in East Asia. Advanced node semiconductors (5nm and below) are produced at TSMC and Samsung facilities in Taiwan and Korea, with no Indian production capability at current advanced nodes. Mid-node semiconductors are produced across Taiwan, Korea, China, Japan and (increasingly) US facilities, with the Tata Electronics fab in Dholera and other Indian projects targeting capacity at mature nodes through 2027-28. Memory semiconductors are dominated by Korean (Samsung, SK Hynix) and US (Micron) producers, with Micron's Sanand assembly and test facility representing the first material Indian memory operation. Substrate and packaging dependencies on East Asia remain comprehensive.
The insurance profile for the sector typically includes CBI cover for named suppliers at INR 100 to 750 crore depending on manufacturer scale and supplier concentration, trade disruption cover for non-physical disruption from export restrictions and political events at INR 50 to 250 crore, and (for larger operations) parametric overlays for specific port and logistics disruption triggers. The 2024-25 China rare-earth and certain chip-category export restrictions, and the periodic Taiwan strait tension cycles, have driven demand for trade disruption capacity in the sector.
Pharmaceutical Manufacturing
The Indian pharmaceutical sector's supply chain exposure centres on API and KSM dependency on China, which by 2024-25 estimates exceeded 70% for the active ingredient base across major drug categories. Government policy under the Bulk Drug Park Scheme and the PLI for API and KSM has targeted reduction of import dependency, with operational results emerging slowly through 2024-26. The leading manufacturers including Sun Pharma, Dr Reddy's, Lupin, Cipla, Aurobindo Pharma, Glenmark, Torrent Pharma, Zydus Lifesciences and Hetero Drugs each face specific dependency profiles by product category that require granular supplier mapping.
The insurance profile typically combines CBI cover for fire and physical perils at named API suppliers at INR 50 to 500 crore, trade disruption cover for export restriction and regulatory disruption events at INR 50 to 250 crore, and product liability cover for downstream consequences of substituted or alternative-sourced APIs at INR 100 to 1,000 crore. The product liability dimension is sector-specific: where substituted APIs produce regulatory or quality issues in finished drug products, the resulting liability exposure can materially exceed the direct supply disruption cost.
Automotive and Electric Vehicle Manufacturing
The automotive sector's supply chain exposure has evolved through the electric vehicle transition. Traditional ICE vehicle production at Maruti Suzuki, Hyundai India, Tata Motors, Mahindra, Toyota Kirloskar and other manufacturers depends on a globalised supplier base with specific concentrations in transmission components, electronic control units, fuel injection systems and emission control equipment. The EV transition introduces new dependencies on lithium-ion battery cells (predominantly Chinese and Korean), battery materials including lithium, cobalt, nickel and graphite (concentrated in specific country sources), permanent magnets containing rare-earth elements (predominantly Chinese), and power electronics requiring specialised semiconductor capacity.
Tata Motors, Mahindra, Ola Electric, Ather Energy, Hero Electric and emerging EV manufacturers each face dependency profiles that change as supplier qualification and domestic capacity develop. The insurance profile includes CBI cover at INR 100 to 500 crore for named tier-1 and tier-2 suppliers, trade disruption cover at INR 50 to 200 crore for the rare-earth and battery materials exposures, and product recall cover at INR 100 to 1,000 crore for the consequences of supplier quality failures in safety-critical components.
Textiles and Apparel
The textile and apparel sector presents different supply chain dynamics. Cotton and yarn supply chains are predominantly domestic with some imports, but synthetic fibre dependencies on Chinese petrochemical sources are material. Dye and chemical dependencies include both Indian production and Chinese imports, with environmental compliance pressure under MoEFCC and state pollution boards affecting domestic capacity utilisation. Garment manufacturer supply chains for retailers and ecommerce platforms involve complex multi-tier arrangements with quality control and compliance documentation requirements that affect supplier qualification.
The insurance profile for textile manufacturers includes CBI cover at INR 25 to 200 crore, fire cover for physical assets, and (for export-oriented operations) trade credit insurance for buyer payment risk. The trade disruption product penetration in textiles is currently limited but growing as larger operators recognise the dependency on imported chemical and synthetic fibre inputs.
The sector-specific risk patterns require sector-specific broker capability. The technology infrastructure broker handling semiconductor and electronics operates with specialised knowledge of fab-level capacity, supplier qualification cycles, and trade restriction frameworks. The life sciences broker handling pharmaceutical operations integrates API supply intelligence with product liability and regulatory cover. The mobility broker handling automotive and EV operations balances traditional automotive supply concerns with the emerging EV-specific dependency profile. The consumer products broker handling textiles and apparel integrates trade credit, supply disruption and operational covers. Manufacturer risk managers selecting brokers for the supply chain risk financing question should specifically evaluate sector capability alongside general broker scale and relationships.
Programme Design: Integrating Mapping, Cover and Operational Mitigations
The supply chain risk financing programme should integrate three components into a coherent operational and financial structure: the supply chain mapping discipline producing the supplier-level visibility, the insurance cover design responding to mapped exposures, and the operational mitigations that reduce exposure before financing becomes necessary. The 2026 Indian manufacturer best practice treats these components as interlocking rather than independent.
The mapping-cover integration produces specific operational practices. The named supplier endorsement schedule on the CBI policy should align directly with the manufacturer's strategic supplier list, with quarterly reviews to add new strategic suppliers and remove exited entities. The trade disruption policy named-peril schedule should align with the supply chain mapping's identified vulnerability categories, with semi-annual reviews to add new identified risks and adjust existing peril definitions. The parametric overlay trigger calibration should reflect the mapping's quantitative estimates of disruption magnitude at the named events.
The mapping-operations integration produces parallel practices. Critical category sourcing decisions should integrate disruption risk assessment, with explicit dual-sourcing policies for categories where single-source dependency creates unmitigated risk. Inventory policy should reflect the mapped dependency profile, with strategic buffer stock at locations and quantities calibrated to expected disruption durations and recovery times. Supplier qualification processes should include disruption risk assessment alongside quality and commercial criteria, with formal scoring and supplier risk grading documented for procurement decisions.
The operational mitigations work alongside insurance to reduce both the frequency and severity of supply chain losses. Strategic buffer inventory at the manufacturer or at intermediate storage locations provides time-based protection against disruption events; the appropriate buffer level varies by category but typically ranges from 30 to 180 days of consumption for critical categories. Dual or multi-source qualification for critical categories provides redundancy against single-supplier events, with the operational cost of multi-source qualification (incremental supplier management, lower volume leverage with individual suppliers) traded against the disruption protection benefit. In-house substitution or production capability for the most critical categories provides ultimate protection, though typically at material capital and operational cost.
The risk financing structure should be designed as a layered programme matching the financial impact distribution of disruption events. Small disruption events (single Tier-1 supplier short outage, single shipment loss, single component category brief shortage) are typically absorbed by operational mitigations and through the deductible layers of insurance cover, without reaching insurance claim payment. Medium disruption events (multi-week outage at a strategic supplier, multi-shipment loss, sustained component shortage) trigger CBI cover payment within standard limits, with operational mitigations limiting the manufacturer's revenue impact during the cover indemnity period. Large disruption events (sector-wide capacity loss, sustained export restriction, multi-supplier cascade failure) approach or exceed cover limits and may trigger trade disruption cover and parametric overlays.
The captive insurance structure provides a fourth risk financing tool that can supplement traditional placement for manufacturers with sufficient scale. GIFT City IFSC captive insurer licensing under IFSCA regulations enables Indian manufacturer captives without offshore jurisdiction requirements. Captives can be structured to retain specific layers of supply chain disruption exposure (typically the high-frequency low-severity layer that commercial insurers price punitively), to write specialised cover that the commercial market does not support effectively, and to access reinsurance markets directly. The captive viability threshold typically applies for manufacturers with consolidated insurance premium spend above INR 25 crore annually; below this scale, captive operational costs typically exceed the financial benefit.
Documentation and Disclosure
The supply chain mapping documentation should be maintained at a quality level that supports insurer underwriting verification and claims response. Standard documentation includes the supplier master list with risk classification, the dependency analysis by category, the operational mitigation plans, the historical disruption event log, the insurer endorsement schedules, and the periodic mapping update cadence. Documentation quality is increasingly an underwriting requirement, with manufacturers maintaining audit-quality documentation receiving more favourable terms.
Disclosure to insurers at placement and renewal must be complete and current. Material changes in the supplier base between renewals (addition of significant new suppliers, exit of previously named suppliers, changes in concentration profile) should be reported to insurers as required by policy disclosure conditions; failure to disclose material changes can void cover or limit response on subsequent claims.
Crisis Response
The crisis response framework should be pre-positioned for the disruption events the mapping has identified. Named supplier outage scenarios should have documented response plans including immediate operational actions (inventory deployment, alternative sourcing activation, production rescheduling), commercial response (customer communication, contractual force majeure considerations, alternative supply commitments), and insurance response (immediate notification, surveyor engagement, claims documentation initiation). The response plans should be tested through tabletop exercises at least annually for the highest-priority scenarios.
[!TIP] Manufacturers with sufficient scale should designate a Supply Chain Risk Committee at the operational leadership level, meeting quarterly, with explicit responsibility for the mapping currency, cover currency, mitigation execution, and crisis response readiness. The committee should report annually to the Board Risk Committee with the full programme status.
Forward View: AI-Driven Mapping, Real-Time Visibility, and FY2026-27 Underwriting Evolution
The supply chain risk financing discipline is evolving rapidly through 2026 and into FY2026-27 along three trajectories that brokers and manufacturer risk managers should plan against. The trajectories arise from AI-driven mapping tool maturation, real-time visibility integration, and underwriter expectations evolution that together will reshape the market structure over the next 24 to 36 months.
The AI-driven mapping trajectory leverages the growing availability of structured supply chain data, the maturation of natural language processing for unstructured data extraction, and the emerging vision and remote sensing capability for facility monitoring. Mapping tools available through 2025-26 increasingly use AI capability to extract Tier-2 and Tier-3 supplier relationships from import-export records, regulatory filings, public news, and structured business data, producing visibility at depths that manual mapping cannot economically achieve. The platforms supporting this capability include the established global providers (Resilinc, Interos, Everstream) and emerging Indian providers, with broker partnerships providing access to manufacturers without the operational scale to deploy enterprise mapping platforms directly.
Real-time visibility integration combines the supplier mapping with operational data flows including production telemetry, logistics movement, supplier capacity status, and external event monitoring. The integration produces a dynamic risk dashboard rather than a periodic mapping document, with early warning indicators for potential disruption events. Insurers underwriting CBI and trade disruption cover are beginning to engage with this dynamic visibility, with selected carriers offering premium discounts for manufacturers providing real-time data feeds and triggering specific cover or pre-loss intervention protocols on defined indicator thresholds. The 2026 implementation is at early stage with limited operational deployment, but the trajectory through FY2026-27 and FY2027-28 will likely produce material market structure evolution.
Underwriter expectations are evolving in parallel. The 2026 underwriting environment increasingly treats documented supply chain mapping as a baseline expectation rather than a differentiating factor. Manufacturers without credible mapping face restricted cover availability, with specific covers including trade disruption and broader CBI scope effectively requiring mapping evidence. The reverse trend is that manufacturers with advanced mapping capability access enhanced cover terms including broader peril scope, named Tier-2 cover, and parametric overlay integration. The bifurcation between mapping-enabled and mapping-deficient manufacturers will likely intensify through FY2026-27.
The IRDAI regulatory framework for supply chain insurance has been informally consultative through 2024-26, with no specific product regulations issued but with general guidance on disclosure, claims handling and exposure management applicable to the segment. The expansion of trade disruption and parametric products in the Indian market may attract more specific regulatory engagement through FY2026-27, with potential framework development addressing product standards, distribution channels, and claims dispute resolution.
The GIFT City IFSC role in supply chain insurance is expected to expand materially. The IFSC framework's clean structure for foreign reinsurer engagement, foreign insurer direct writing for offshore-eligible risks, and captive insurer licensing all support the supply chain insurance segment specifically. Indian manufacturers placing large or complex supply chain programmes increasingly engage GIFT City structures alongside onshore market access, with the operational maturity of the IFSC sector improving the practical placement experience.
The Indian manufacturer maturity gradient creates differentiated practice patterns across the supply chain risk financing question. Tier-1 manufacturers (top quartile by revenue and corporate sophistication) operate near-global-standard mapping and insurance programmes with dedicated supply chain risk functions, board-level oversight, and multi-tier cover layering. Tier-2 manufacturers operate documented mapping and basic CBI cover with limited trade disruption engagement. Tier-3 manufacturers operate limited mapping and standard BI cover without supply chain extensions. The bifurcation will likely intensify through FY2026-27 as the leading manufacturers' approach becomes the implicit market standard for major insurance placements.
For brokers building practice in the supply chain risk financing area, four positioning options apply. The general commercial broker can serve smaller manufacturers with standard CBI cover and basic mapping support, with limited specialty depth. The sector-specific broker (semiconductor, pharma, automotive, textiles) can serve larger manufacturers with deep sector knowledge and tailored cover structuring. The supply chain specialty broker can serve manufacturers across sectors with deep mapping and risk financing capability, typically operating within larger broker firms. The integrated broker combines sector and specialty capability with treaty access and GIFT City engagement, supporting the most sophisticated manufacturer clients.
Platforms supporting integrated supply chain risk financing including mapping tool integration, cover design across CBI, trade disruption and parametric heads, GIFT City structuring, and ongoing programme management are emerging in the Indian market. Sarvada supports brokers in delivering this integrated capability for manufacturer clients with complex supply chain exposure. Request Access to evaluate the platform fit for supply chain risk financing engagements.
The supply chain risk financing discipline is well established in mature markets and is becoming established in India through 2026. The Indian manufacturer base is large enough, sufficiently exposed to global supply chain dependencies, and increasingly sophisticated in corporate risk management to support the full range of supply chain risk financing products. The next 24 to 36 months will likely see the segment maturity gap to global practice close materially, with Indian manufacturer programmes approaching global standard in mapping rigour, cover scope and integration with operational risk management.